Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the ... - UroToday
The VA Health Care System developed a phase II/III RCT for oligometastatic prostate cancer, addressing challenges in study development/conduct and adapting the trial to include de novo OMPC patients and up to 10 metastases.
Highlighted Terms
Louis Stokes Cleveland VA Medical CenterEdward Hines Jr. VA HospitalVA Long Beach Healthcare SystemDurham VA Medical CenterClement J. Zablocki VA Medical CenterUnited States Veterans Affairs (VA) Health Care SystemMinneapolis VA Medical CenterVA Connecticut Healthcare SystemCooperative Studies ProgramCorporal Michael J. Crescenz VA Medical CenterRichmond VA Medical Centeroligometastatic prostate cancer (OMPC)VA STARPORT Investigators GroupRichard L. Roudebush VA Medical CenterVA Greater Los Angeles Healthcare SystemMichael E. DeBakey VA Medical Center
Related News
Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the ... - UroToday
The VA Health Care System developed a phase II/III RCT for oligometastatic prostate cancer, addressing challenges in study development/conduct and adapting the trial to include de novo OMPC patients and up to 10 metastases.